Cepatwawasan Group Berhad Future Growth
Future criteria checks 0/6
Wir verfügen derzeit nicht über ausreichende Analystenabdeckung, um Wachstum und Umsatz für Cepatwawasan Group Berhad zu prognostizieren.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Food earnings growth | 10.3% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Cepatwawasan Group Berhad (KLSE:CEPAT) Could Easily Take On More Debt
Oct 19Cepatwawasan Group Berhad (KLSE:CEPAT) Is Doing The Right Things To Multiply Its Share Price
Jun 13These 4 Measures Indicate That Cepatwawasan Group Berhad (KLSE:CEPAT) Is Using Debt Safely
Mar 17Cepatwawasan Group Berhad's (KLSE:CEPAT) Returns On Capital Are Heading Higher
Feb 23Here's Why We Think Cepatwawasan Group Berhad (KLSE:CEPAT) Is Well Worth Watching
Oct 06Cepatwawasan Group Berhad (KLSE:CEPAT) Might Have The Makings Of A Multi-Bagger
Mar 28Read This Before Buying Cepatwawasan Group Berhad (KLSE:CEPAT) For Its Dividend
Feb 21We Think Cepatwawasan Group Berhad (KLSE:CEPAT) Can Stay On Top Of Its Debt
Jan 31Are Cepatwawasan Group Berhad's (KLSE:CEPAT) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Jan 05Cepatwawasan Group Berhad's (KLSE:CEPAT) Stock Price Has Reduced 16% In The Past Three Years
Dec 15Will Cepatwawasan Group Berhad (KLSE:CEPAT) Multiply In Value Going Forward?
Nov 27In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Cepatwawasan Group Berhad has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2023 | 305 | 20 | 32 | 39 | N/A |
9/30/2023 | 297 | 10 | 19 | 29 | N/A |
6/30/2023 | 297 | 7 | 16 | 26 | N/A |
3/31/2023 | 332 | 19 | 33 | 41 | N/A |
12/31/2022 | 357 | 32 | 49 | 56 | N/A |
9/30/2022 | 407 | 58 | 77 | 83 | N/A |
6/30/2022 | 433 | 67 | 85 | 90 | N/A |
3/31/2022 | 407 | 60 | 85 | 91 | N/A |
12/31/2021 | 363 | 51 | 75 | 81 | N/A |
9/30/2021 | 303 | 32 | 56 | 64 | N/A |
6/30/2021 | 263 | 26 | 52 | 61 | N/A |
3/31/2021 | 237 | 21 | 38 | 47 | N/A |
12/31/2020 | 235 | 15 | 30 | 42 | N/A |
9/30/2020 | 225 | 9 | 24 | 39 | N/A |
6/30/2020 | 210 | 1 | 12 | 33 | N/A |
3/31/2020 | 211 | -3 | 6 | 28 | N/A |
12/31/2019 | 215 | 0 | 7 | 29 | N/A |
9/30/2019 | 216 | -2 | 0 | 19 | N/A |
6/30/2019 | 212 | -1 | -3 | 12 | N/A |
3/31/2019 | 220 | 1 | -5 | 7 | N/A |
12/31/2018 | 241 | 5 | 5 | 19 | N/A |
9/30/2018 | 261 | 11 | 13 | 25 | N/A |
6/30/2018 | 283 | 19 | 25 | 36 | N/A |
3/31/2018 | 288 | 27 | 32 | 47 | N/A |
12/31/2017 | 274 | 24 | 28 | 42 | N/A |
9/30/2017 | 281 | 27 | N/A | 41 | N/A |
6/30/2017 | 294 | 31 | N/A | 39 | N/A |
3/31/2017 | 275 | 26 | N/A | 33 | N/A |
12/31/2016 | 255 | 21 | N/A | 25 | N/A |
9/30/2016 | 228 | 15 | N/A | 34 | N/A |
6/30/2016 | 222 | 8 | N/A | 29 | N/A |
3/31/2016 | 225 | 6 | N/A | 20 | N/A |
12/31/2015 | 228 | 10 | N/A | 18 | N/A |
9/30/2015 | 240 | 14 | N/A | -1 | N/A |
6/30/2015 | 221 | 13 | N/A | -12 | N/A |
3/31/2015 | 236 | 18 | N/A | 2 | N/A |
12/31/2014 | 244 | 21 | N/A | 3 | N/A |
9/30/2014 | 259 | 31 | N/A | -10 | N/A |
6/30/2014 | 258 | 33 | N/A | 6 | N/A |
3/31/2014 | 239 | 27 | N/A | 6 | N/A |
12/31/2013 | 234 | 25 | N/A | 10 | N/A |
9/30/2013 | 196 | 17 | N/A | 25 | N/A |
6/30/2013 | 199 | 19 | N/A | 19 | N/A |
Analyst Future Growth Forecasts
Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von CEPAT über der Sparquote liegt (3.6%).
Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von CEPAT schneller wachsen werden als der Markt MY
Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von CEPAT in den nächsten 3 Jahren signifikant steigen werden.
Einnahmen vs. Markt: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von CEPAT schneller wachsen werden als der Markt von MY.
Hohe Wachstumseinnahmen: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Einnahmen von CEPAT schneller wachsen werden als 20% pro Jahr.
Earnings per Share Growth Forecasts
Future Return on Equity
Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von CEPAT in 3 Jahren voraussichtlich hoch sein wird